HLA Typing for Transplant Market size worth over $1.12bn by 2026

HLA Typing for Transplant Market size is set to surpass USD 1.12 billion by 2026, according to a new research report by Global Market Insights, Inc.

HLA typing for transplant market growth is owing to advancement in technologies, novel product launches and approvals as well as increasing demand for HLA typing. For instance, in November 2017, Omixon launched its HLA Holotype V2.1 and V2.2, an NGS-based HLA typing solution with improved allele coverage and amplification robustness and decreased turnaround time. Such novel product launch could enable market players to deliver optimal consumer experience. Moreover, regulatory bodies play a vital role in managing and ensuring safety parameters that will further drive the market value.


Request Sample Buy NowInquiry Before Buying


Growing demand for solid organ transplantations will spur the market expansion

Increasing demand for solid organ transplantations is driving the market on account of growing number of chronic disorders leading to permanent organ damage. Furthermore, rising number of end-stage kidney disorders will further fuel the demand for kidney transplants. HLA typing is a fundamental process of organ transplantations as it matches the donor organ with the receiver. Additionally, increasing number of people waiting for organ transplant coupled with growing awareness pertaining to organ transplantations will foster the market share.

Significant gap between number of organs donated and organs required may hamper the HLA typing for transplant market revenue

Despite advances in medical technology and rising awareness of organ transplantation, there continues to be a considerable gap between supply and demand. The demand generated do not match the number of organs that are being donated. Kidney accounts for the largest share of the organ shortage with about 83% patients on waiting list for kidney transplant as on March 2020. According to the Organ Procurement and Transplantation Network (OPTN), about 112,500 patients were on organ transplant waiting list as of 2019. This creates a huge gap between demand and supply of organ donations, thus hampering the industry growth. As the number of surgeries is increasing it generates a further demand for the organ donors which is not increasing in the equal proportion.

Sanger sequencing offers wide range of applications in research fields

Sanger sequencing segment held significant HLA typing for transplant market share in 2019 due to wide-ranging applications in the fields of research coupled with launch of HLA typing Sanger sequencing products. Sanger sequencing is DNA sequencing method that is based on integration of chain terminating dideoxy nucleotides by DNA polymerase through in vitro DNA replication. In addition, associated advantages with Sanger sequencing encourages customer buying behavior.

Availability of different type of kits will boost the market size

The reagents and consumables accounted for USD 302.4 million revenue in 2019. Reagents and consumables are used in large quantity and are frequently required for performing HLA typing. Diverse types of kits are available such as SBT kits (sequencing-based typing), SSO kits (sequence-specific oligonucleotides), SSP kits (sequence-specific primers) and next generation sequencing based kits. Associated advantages and availability of different types of reagents and consumables will augment the segment growth.

Browse key industry insights spread across 235 pages with 353 market data tables & 20 figures & charts from the report,HLA Typing for Transplant Market Size, By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents and Consumables, Software, Services), By Application (Diagnostics, Research), By End-Use (Hospitals, Diagnostic Labs, Academic and Research Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026in detail along with the table of contents:

HLA typing has various applications in disease research that will positively influence the HLA typing for transplant market demand

The research application segment revenue was around of USD 132 million in 2019. HLA typing has various applications in disease research and has potential in other areas such as forensic and population genetics. Researchers have developed statistical approach that uses high-quality HLA data to decrease ambiguity in lower-quality data sets. HLA genotypes are associated with infectious and autoimmune diseases.

Cost-effectiveness and high resolution of HLA typing in diagnostics labs will attract significant customer base

Diagnostic labs end-use segment in the HLA typing for transplant market will observe substantial growth from 2020 to 2026. HLA matching promotes growth and progress of new healthy blood cells and decrease risk associated with post-transplant problem that is known as graft-versus-host (GVHD) disease. Moreover, severe congenital and acquired bone marrow disease treatment is possible with development in application of stem cell transplantation. Diagnostic laboratories offer a cost-effective choice and performs HLA typing at high resolution as well as higher volume that will positively impact the market size over the forecast period.

Increasing number of organ transplantation in Europe will propel the regional market growth

Europe HLA typing for transplant market will showcase growth of 9.7% through 2026 driven by organ and stem cell transplant industry across the region. In past few years, there have been continuous increase in number of organ transplantations performed. The region has high potential for HLA typing for organ transplant. A large number of population intends to opt for organ transplant, but organ donation is sparse. For instance, about 60 thousand patients are on waiting lists of organ transplant across the European region. This creates huge demand for organ transplantation.

Companies undertake inorganic growth strategies to strengthen their business portfolio and revenue

The eminent players operating in the HLA typing for transplant market include Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc, Luminex Corporation and Immucor, Inc among others. These companies focus on strategies such as acquisitions & mergers, innovative product development and partnerships to garner more revenue and sustain market competition.

Explore More on Related Topics:

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X